Drugs Health Pharma

FDA clears Asahi Kasei’s oral drug to treat herpes virus in immunodeficient

The US Food and Drug Administration has approved Asahi Kasei Therapeutics, Inc’s oral drug to treat mucocutaneous lesions caused by herpes simplex virus.

Read More
Drugs Health Pharma

1 person contracts genital herpes infection every second in the world

About one person every second or 42 million people each year are estimated to contract genital herpes infection worldwide, according to the World.

Read More